Luciferase-induced immune activation prevents orthotopic K7M2luc osteosarcoma establishment in BALB/c mice
References
- Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3-13. doi: 10.1007/978-1-4419-0284-9_1
- Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001-10: a populationbased registry study. Lancet Oncol 2017; 18: 719-31. doi: 10.1016/S1470-2045(17)30186-9
- Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer 2005; 41: 2836-45. doi: 10.1016/J.EJCA.2005.08.026
- Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Bruijn IB De, De Jong D, et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 2009; 219: 294-305. doi: 10.1002/path.2603
- Fletcher CDM, Mertens F, Unni K, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone [Internet]. IARC Press; 2002. [cited 2026 Jan 05]. Available at: https://portal.research.lu.se/en/publications/world-health-organization-classification-of-tumours-pathology-and/
- Corre I, Verrecchia F, Crenn V, Redini F, Trichet V. The osteosarcoma microenvironment: a complex but targetable ecosystem. Cells 2020; 9: 1-25. doi: 10.3390/cells9040976.
- Miyamoto N, Higuchi Y, Mori K, Ito M, Tsurudome M, Nishio M, et al. Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells. Int Immunopharmacol 2002; 2: 25-38. doi: 10.1016/S1567-5769(01)00134-5
- Rubio R, Abarrategi A, Garcia-Castro J, Martinez-Cruzado L, Suarez C, Tornin J, et al. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells. Stem Cells 2014; 32: 1136-48. doi: 10.1002/STEM.1647
- Omerzel M, Markelc B, Kranjc Brezar S, Sersa G, Cemazar M, Čemažar M. Efficient gene transfer by pulse parameters for electrochemotherapy of cells in vitro and in muscle and melanoma tumors in mice. Radiol Oncol 2025; 59: 203-12. doi: 10.2478/raon-2025-0027
- Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1999; 17: 279-84. doi: 10.1023/a:1006140513233
- Lwin TM, Hoffman RM, Bouvet M. Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery. J Surg Oncol 2018; 118: 253-64. doi: 10.1002/jso.25150
- Denda-Nagai K, Fujita K, Fujime M, Nakatsugawa S, Ishigaki T, Irimura T. Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems. Clin Exp Metastasis 2000; 18: 77-81. doi: 10.1023/a:1026508402526
- Fidler IJ. Experimental orthotopic models of organ-specific metastasis by human neoplasms. Adv Molec Cell Biol 1994; 9: 191-215. doi: 10.1016/S1569-2558(08)60385-9
- Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 1994; 13: 209-22. doi: 10.1007/BF00689637
- Sangeetha B, Leroy KI, Udaya Kumar B. Harnessing bioluminescence: a comprehensive review of in vivo imaging for disease monitoring and therapeutic intervention. Cell Biochem Funct 2024; 42: e70020. doi: 10.1002/CBF.70020
- England CG, Ehlerding EB, Cai W. NanoLuc: a small luciferase is brightening up the field of bioluminescence. Bioconjug Chem 2016; 27: 1175. doi: 10.1021/acs.bioconjchem.6b00112
- Amadeo F, Plagge A, Chacko A, Wilm B, Hanson V, Liptrott N, et al. Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies. Eur J Nucl Med Mol Imaging 2022; 49: 796-808. doi: 10.1007/s00259-021-05439-4
- Garimella R, Eskew J, Bhamidi P, Vielhauer G, Hong Y, Anderson HC, et al. Biological characterization of preclinical Bioluminescent Osteosarcoma Orthotopic Mouse (BOOM) model: a multi-modality approach. J Bone Oncol 2013; 2: 11. doi: 10.1016/J.JBO.2012.12.005
- Liu S, Su Y, Lin MZ, Ronald JA. Brightening up biology: advances in luciferase systems for in vivo imaging. ACS Chem Biol 2021; 16: 2707. doi: 10.1021/ACSCHEMBIO.1C00549
- Ferrari DP, Ramos-Gomes F, Alves F, Markus MA. KPC-luciferase-expressing cells elicit an anti-tumor immune response in a mouse model of pancreatic cancer. Sci Rep 2024; 14: 1-12. doi: 10.1038/s41598-024-64053-0
- Basnet A, Thomas DD, Landreth KM, Damron FH, Liu TW. Immune response to bioluminescence imaging reporters in murine tumor models. Mol Imaging Biol 2025; 27: 341. doi: 10.1007/s11307-025-02010-7
- Brutkiewicz S, Mendonca M, Stantz K, Comerford K, Bigsby R, Hutchins G, et al. The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging. Luminescence 2007; 22: 221-8. doi: 10.1002/BIO.953;CTYPE:STRING:JOURNAL
- Petkov SP, Heuts F, Krotova OA, Kilpelainen A, Engström G, Starodubova ES, et al. Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging. Hum Vaccin Immunother 2013; 9: 2228. doi: 10.4161/hv.25561
- Kamensek U, Rols M-P, Cemazar M, Golzio M. Visualization of nonspecific antitumor effectiveness and vascular effects of gene electro-transfer to tumors. Curr Gene Ther 2016; 16: 90-7. doi: 10.2174/1566523216666160331125611
- Baklaushev VP, Kilpeläinen A, Petkov S, Abakumov MA, Grinenko NF, Yusubalieva GM, et al. Luciferase expression allows bioluminescence imaging but imposes limitations on the orthotopic mouse (4T1) model of breast cancer. Sci Rep 2017; 7: 7715. doi: 10.1038/S41598-017-07851-Z
- Grisez BT, Ray JJ, Bostian PA, Markel JE, Lindsey BA. Highly metastatic K7M2 cell line: a novel murine model capable of in vivo imaging via luciferase vector transfection. J Orthop Res 2018; 36: 2296-304. doi: 10.1002/jor.23868
- Sanchez VE, Lynes JP, Walbridge S, Wang X, Edwards NA, Nwankwo AK, et al. GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models. Sci Rep 2020; 10: 11003. doi: 10.1038/s41598-020-67411-w
- Liang Y, Walczak P, Bulte JWM. Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells. J Biomed Opt 2012; 17: 016004. doi: 10.1117/1.jbo.17.1.016004
- Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA et al. Bioluminescent imaging of melanoma in live mice. J Invest Dermatol 2005; 125: 159-65. doi: 10.1111/J.0022-202X.2005.23759.X
- Smakman N, Martens A, Kranenburg O, Borel Rinkes IHM. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res 2004; 122: 225-30. doi: 10.1016/j.jss.2004.05.021
- Tiffen JC, Bailey CG, Ng C, Rasko JEJ, Holst J. Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo. Mol Cancer 2010; 9: 299. doi: 10.1186/1476-4598-9-299.
- Perrone F, Craparo EF, Cemazar M, Kamensek U, Drago SE, Dapas B, et al. Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer. J Control Release 2021; 330: 1132-51. doi: 10.1016/j.jconrel.2020.11.020
- Limberis MP, Bell CL, Wilson JM. Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene Ther 2009; 16: 441. doi: 10.1038/GT.2008.177
- Petkov S, Starodubova E, Latanova A, Kilpeläinen A, Latyshev O, Svirskis S, et al. DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response. PLoS One 2018; 13: e0197902. doi: 10.1371/JOURNAL.PONE.0197902
- Mezzapelle R, De Marchis F, Passera C, Leo M, Brambilla F, Colombo F, et al. CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma. EMBO Mol Med 2021; 13: e12344. doi: 10.15252/EMMM.202012344
- Dicks MDJ, Spencer AJ, Coughlan L, Bauza K, Gilbert SC, Hill AVS, et al. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice. Sci Rep 2015; 5: 16756. doi: 10.1038/srep16756
- Jansons J, Sominskaya I, Petrakova N, Starodubova ES, Smirnova OA, Alekseeva E, et al. The immunogenicity in mice of HCV core delivered as DNA is modulated by its capacity to induce oxidative stress and oxidative stress response. Cells 2019; 8: 208. doi: 10.3390/CELLS8030208
- Burgos JS, Rosol M, Moats RA, Khankaldyyan V, Kohn DB, Nelson MD, et al. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. Biotechniques 2003; 34: 1184-8. doi: 10.2144/03346ST01
- Grisez BT, Ray JJ, Bostian PA, Markel JE, Lindsey BA. Highly metastatic K7M2 cell line: a novel murine model capable of in vivo imaging via luciferase vector transfection. J Orthop Res 2018; 36: 2296-304. doi: 10.2144/03346ST01
- Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol 2010; 125: 33-40. doi: 10.1016/j.jaci.2009.09.017
- Yu S, Yao X. Advances on immunotherapy for osteosarcoma. Mol Cancer 2024; 23: 192. doi: 10.1186/S12943-024-02105-9
- Owyang SY, Zhang M, Walkup GA, Chen GE, Grasberger H, El-Zaatari M, et al. The effect of CT26 tumor-derived TGF-ß on the balance of tumor growth and immunity. Immunol Lett 2017; 191: 47. doi: 10.1016/j.IMLET.2017.08.024
- Hong ZF, Zhao WX, Yin ZY, Xie CR, Xu YP, Chi XQ, et al. Natural killer cells inhibit pulmonary metastasis of hepatocellular carcinoma in nude mice. Oncol Lett 2016; 11: 2019-26. doi: 10.3892/OL.2016.4170
- Yao M, Lei Z, Peng F, Wang D, Li M, Zhong G, et al. Establishment of orthotopic osteosarcoma animal models in immunocompetent rats through muti-rounds of in-vivo selection. BMC Cancer 2024; 24: 703. doi: 10.1186/S12885-024-12361-Z
- Wu H, He Z, Li X, Xu X, Zhong W, Bu J, et al. Efficient and consistent orthotopic osteosarcoma model by cell sheet transplantation in the nude mice for drug testing. Front Bioeng Biotechnol 2021; 9: 690409. doi: 10.3389/FBIOE.2021.690409/BIBTEX
- Beck J, Ren L, Huang S, Berger E, Bardales K, Mannheimer J, et al. Canine and murine models of osteosarcoma. Vet Pathol 2022; 59: 399-414. doi: 10.1177/03009858221083038
- Kavirayani AM, Foreman O. Retrospective study of spontaneous osteosarcomas in the nonobese diabetic strain and nonobese diabetic-derived substrains of mice. Vet Pathol 2010; 47: 482-7. doi: 10.1177/0300985810363699
- Lampreht Tratar U, Kos S, Kamensek U, Ota M, Tozon N, Sersa G, et al. Antitumor effect of antibiotic resistance gene-free plasmids encoding interleukin-12 in canine melanoma model. Cancer Gene Ther 2018; 25: 260-73. doi: 10.1038/S41417-018-0014-5
- Yong HJ, Choi Y, Joo HK, Chul WK, Jae MJ, Dong SL, et al. Immune response to firefly luciferase as a naked DNA. Cancer Biol Ther 2007; 6: 781-6. doi: 10.4161/CBT.6.5.4005
- Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev 2018; 32: 1267. doi: 10.1101/GAD.314617.118
- Khan KA, Qureshi AA, Xu P, Kuo HY, Schumacher TN, Michael IP, et al. Immunological tolerance to luciferase and fluorescent proteins using Tol mice enables development of improved tumor models for investigating immunity and metastasis. Cancer Res 2025; 85: 2165-78. doi: 10.1158/0008-5472.CAN-24-2418
Language: English
Page range: 402 - 415
Submitted on: Aug 17, 2026
Accepted on: Aug 21, 2026
Published on: Sep 7, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Sasa Kupcic, Urska Kamensek, Maja Cemazar, Ursa Lampreht Tratar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.